FBP1 dysregulation provided metabolic advantages and promoted cancer progression in various cancers, including renal cancer8, breast cancer9, HCC23,24, lung cancer10, pancreatic cancer11,12 and gastric cancer13. This evidence concerns the gene FBP1 and cancer.